Sharma, L C <br/><br/>
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years.  [electronic resource] 

 -  Transplantation proceedings   
 - 323-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(97)82528-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Creatinine--blood<br/>Follow-Up Studies<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunosuppression Therapy<br/>Kidney Transplantation--immunology<br/>Mice<br/>Muromonab-CD3--therapeutic use<br/>Recombinant Fusion Proteins--therapeutic use<br/>Time Factors